Precision oncology innovation is accelerating as the Neoantigen Targeted Therapy Market advances toward fully individualized cancer treatment strategies built around tumor-specific genetic mutations. Neoantigens are unique protein markers created by mutations present only in cancer cells, enabling therapies that train the immune system to recognize tumors without damaging healthy tissues....